Evaluation of the antifungal efficacy of Salvia officinalis extract against some clinical oral candidiasis isolates: a comparative study with standard antifungals
DOI:
https://doi.org/10.65405/95gkdw08الكلمات المفتاحية:
Salvia officinalis, Candida albicans, Antifungal activity, Oral candidiasisالملخص
Background: Oral candidiasis is an opportunistic fungal infection caused by Candida spp. Although these yeasts are a normal inhabitant of the mouth in a large percentage of people, they can become pathogenic under suitable conditions. With increasing resistance to conventional antifungals, the need to discover effective natural alternatives has become apparent.
Objective: This study aimed to evaluate the inhibitory efficacy of an ethanolic extract of S. officinalis against three Candida isolates from patients with oral candidiasis.
Materials and Methods: involved preparing an ethanolic extract of S. officinalis and testing the susceptibility of the isolates using the disc diffusion method, comparing the results with the efficacy of some standard antifungal agents.
Results: The results showed that S. officinalis extract inhibited the growth of C. albicanis, with an average aura diameter of 19.5 ± 1.18 at 100% concentration. Compared to standard antifungal agents, the extract demonstrated superior efficacy, surpassing amphotericin B, which showed the highest effect on all three isolates. The average aura diameter for C. tropicalis was 25.17 ± 1.86 at 100%, while C. parapsilosis was the least affected by the extract.
Conclusions: The study concludes that S. officinalis extract possesses antifungal properties, making it a promising alternative for developing topical treatments for oral fungal infections.
التنزيلات
المراجع
1- Ghorbani A., and Esmaeilizadeh M. (2017). Pharmacological properties of Salvia officinalis and its components. Journal of Traditional and Complementary Medicine, 7(4), 433–440.
2- Trivedi H., Panchal U., and Patani P. (2024). The saviour sage: Unveiling its multifaceted marvels—a comprehensive exploration of its anti-inflammatory, mood and memory modulating, anti-sweating, and hot flashes relieving properties. J Popul Ther Clin Pharmacol, 31(1), 683–701.
3- Zeidabadi A., Yazdanpanahi Z., Dabbaghmanesh M. H., Sasani M. R., Emamghoreishi M., and Akbarzadeh M. (2020). The effect of Salvia officinalis extract on symptoms of flushing, night sweat, sleep disorders, and score of forgetfulness in postmenopausal women. J Fam Med Prim Care, 9(3), 1086–1092.
4- Ilić Z. S., Kevrešan Ž., Šunić L., Stanojević L., Milenković L., Stanojević J., Milenković A., and Cvetković D. (2023). Chemical profiling and antioxidant activity of wild and cultivated sage (Salvia officinalis L.) essential oil. Horticulturae, 9(6), 62. https://doi.org/10.3390/horticulturae9060624
5- Levaya Y., Atazhanova G., Gabe V., and Badekova, K. (2025). A review of botany, phytochemistry, and biological activities of eight Salvia species widespread in Kazakhstan. Molecules, 30(5), 1142
6- Molek M., Florenly F., Lister I.N.E., Abdul Wahab T., Lister C. and Fioni F. (2022) 'Xerostomia and hyposalivation in association with oral candidiasis: a systematic review and meta-analysis', Evidence-Based Dentistry, 23(1), pp. 30-31. Available at: https://doi.org/10.1038/s41432-021-0210-2
7- Liang X., Chen D., Wang J., Liao B., Shen, J., Ye X., Wang Z., Zhu C., Gou L., Zhou X., Cheng L., Ren B and Zhou X. (2023) 'Artemisinins inhibit oral candidiasis caused by Candida albicans through the repression on its hyphal development', International Journal of Oral Science, 15(1), 40. Available at: https://doi.org/10.1038/s41368-023-00245-0
8- Talapko J., Juzbašić M., Matijević T., Pustijanac E., Bekić S., Kotris I. and Škriec, I. (2021) 'Candida albicans—The Virulence Factors and Clinical Manifestations of Infection', Journal of Fungi, 7(2), p. 79. Available at: https://doi.org/10.3390/jof7020079
9- Gharibpour F., Shirban F., Bagherniya M., Nosouhian M., Sathyapalan T. and Sahebkar A. (2020). The effects of nutraceuticals and herbal medicine on Candida albicans in oral candidiasis: a comprehensive review. Springer, Cham. Available from: http://dx.doi. org/10.1007/978-3-030-64872-5_16
10- Fang J., Huang B. and Ding, Z. (2020) 'Efficacy of antifungal drugs in the treatment of oral candidiasis: A Bayesian network meta-analysis', The Journal of Prosthetic Dentistry. Available at: https://doi.org/10.1016/j.prosdent.2019.12.025
11- Bhattacharya S., Sae-Tia S. and Fries B.C. (2020) 'Candidiasis and Mechanisms of Antifungal Resistance', Antibiotics, 9(6), p. 312. Available at: https://doi.org/10.3390/ antibiotics 9060312
12- Kumar C., Sharma R., and Sharma S. (2013). In vitro effects of Salvia officinalis L. essential oil on Candida albicans. BMC Complementary and Alternative Medicine, 13, 204. https://doi.org/10.1016/S2221-1691(13)60080-5
13- Maliki, I., Moussaoui, A.E., Ramdani, M. and ELBadaoui, K., 2021. Phytochemical screening and the antioxidant, antibacterial and antifungal activities of aqueous extracts from the leaves of Salvia of ficinalis planted in Morocco. Moroccan Journal of Chemistry, 9(2). https://doi.org/10.48317/IMIST.PRSM/morjchem-v9i2.24840
14- Proškovcová M., Čonková E., Váczi P., Harčárová M., and Malinovská Z. (2021). Antibiofilm activity of selected plant essential oils from the Lamiaceae family against Candida albicans clinical isolates. Annals of Agricultural and Environmental Medicine, 28(2), 260–266
15- Aćimović, M., Pezo, L., Čabarkapa, I., Trudić, A., Stanković Jeremić, J., Varga, A., and Tešević, V. (2022). Variation of Salvia officinalis L. essential oil and hydrolate composition and their antimicrobial activity. Processes, 10(8), 1608.https://doi.org/ 10.3390/pr10081608
16- Sweedan E.G.(2021). The Antimicrobial effects of alcoholic leaves extract of Salvia Officinalis against multidrug resistant Pseudomonas aeruginosa. Iraqi journal of science. pp.441-448. https://doi.org/10.24996/ijs.2021.62.2.9
17- Khan B.M., Bakht J. and Shafi M. (2017) Screening of leaves extracts from Calamus aromaticus for their antimicrobial activity by disc diffusion assay. Pakistani Journal of Pharmaceutical Sciences, 30(3), pp. 793-800.
18- Nic Gabhainn S., Bergh Ø., Dixon B., Donachie L., Carson J., Coyne R., Curtin J., Dalsgaard I., Manfrin A., Maxwell G. and Smith, P. (2004). The precision and robustness of published protocols for disc diffusion assays of antimicrobial agent susceptibility: an inter-laboratory study. Aquaculture. 240(1-4), pp.1-18. https://doi.org/10.1016/ j.aquaculture.2004.02.004
19- Fioriti, S., Brescini, L., Pallotta, F., Canovari, B., Morroni, G., and Barchiesi, F. (2022). Antifungal combinations against Candida species: from bench to bedside. Journal of Fungi, 8(10), 1077.
20- Xiao, Y., Yuan, P., Sun, Y., Xu, Y., Deng, X., Wang, X., and Jiang, L. (2022). Comparison of topical antifungal agents for oral candidiasis treatment: a systematic review and meta-analysis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 133(3), 282-291. https://doi.org/10.1016/j.oooo.2021.10.023
21- Kessler, S. Q. S., Lang, P. M., Dal-Pizzol, T. S., and Montagner, F. (2022). Resistance profiles to antifungal agents in Candida albicans isolated from human oral cavities: systematic review and meta-analysis. Clinical Oral Investigations, 26(11), 6479-6489. https://doi.org/10.1007/s00784-022-04716-2
22- Bao, K., Liang, Y., Zhu, L., Wu, S., Zhao, X., Ni, S., and Wu, W. (2025). Amphotericin B Delivery Systems: Current Advances and Potential Directions in Oral Candidiasis Treatment. Precision Medicine and Engineering, 100021. https://doi.org/10.1016/ j.preme.2025.100021
23- Demir, K. K., Butler‐Laporte, G., Del Corpo, O., Ekmekjian, T., Sheppard, D. C., Lee, T. C., and Cheng, M. P. (2021). Comparative effectiveness of amphotericin B, azoles and echinocandins in the treatment of candidemia and invasive candidiasis: A systematic review and network meta‐analysis. Mycoses, 64(9), 1098-1110. https://doi.org/10.1111/ myc.13290
24- Ahmady, L., Gothwal, M., Mukkoli, M. M., and Bari, V. K. (2024). Antifungal drug resistance in Candida: a special emphasis on amphotericin B. Apmis, 132(5), 291-316.https://doi.org/10.1111/apm.13389
25- Alkhars, N., Gaca, A., Zeng, Y., Al-Jallad, N., Rustchenko, E., Wu, T. T., and Xiao, J. (2023). Antifungal susceptibility of oral Candida isolates from mother-infant dyads to nystatin, fluconazole, and caspofungin. Journal of Fungi, 9(5), 580.https://doi.org/ 10.3390/ jof9050580
26- Shrivastava, M., Kouyoumdjian, G. S., Kirbizakis, E., Ruiz, D., Henry, M., Vincent, A. T., and Whiteway, M. (2023). The Adr1 transcription factor directs regulation of the ergosterol pathway and azole resistance in Candida albicans. MBio, 14(5), e01807-23. https://doi.org/10.1128/mbio.01807-23
27- Tkaczyk, M., Kuśka-Kielbratowska, A., Fiegler-Rudol, J., Niemczyk, W., Mertas, A., Skaba, D., and Wiench, R. (2025). The Prevalence and Drug Susceptibility of Candida Species and an Analysis of Risk Factors for Oral Candidiasis—A Retrospective Study. Antibiotics, 14(9), 876. https://doi.org/10.3390/antibiotics14090876
28- Ruiz-Baca, E., Arredondo-Sánchez, R. I., Corral-Pérez, K., López-Rodríguez, A., Meneses-Morales, I., Ayala-García, V. M., and Martínez-Rocha, A. L. (2021). Molecular mechanisms of resistance to antifungals in Candida albicans. In Advances in Candida albicans. https://doi.org/10.5772/intechopen.96346
29- Pereira, R., dos Santos Fontenelle, R. O., De Brito, E. H. S., and De Morais, S. M. (2021). Biofilm of Candida albicans: formation, regulation and resistance. Journal of applied microbiology, 131(1), 11-22. https:// doi.org/10.1111/jam.14949
30- Deshmukh, V. P. (2022). Phytochemistry and Pharmacology of Salvia officinalis L.: a review. Bioactives and pharmacology of medicinal plants, 339-358.
31- Ghadaksaz, S., Farajnia, S., Pournaghiazar, F., Leylabadlo, H. E., Salahlou, R., Delazar, A., and Zandesh, A. (2025). Antimicrobial efficacy and cytotoxicity of ethanolic extracts of Salvia officinalis and Juglans regia against oral pathogens. Journal of Advanced Periodontology & Implant Dentistry, 17(1), 46.
32- Chitrapu, P., and Pandey, A. N. (2025). Phytochemical Screening, Anti-microbial Evaluation of Extract of Salvia officinalis L. Vascular and Endovascular Review, 8(11s), 366-374.
33- Karpiński, T. M., Ożarowski, M., Seremak-Mrozikiewicz, A., and Wolski, H. (2023). Anti-Candida and antibiofilm activity of selected Lamiaceae essential oils. Frontiers in Bioscience-Landmark, 28(2), 28.
34- Garg, D., and Kumar, V. (2024). A review of therapeutic properties and uses of Salvia officinalis. Journal of Pharma Insights and Research, 2(3), 146-154.
35- Garghani, M., Asfaram, A., Roustaee, N., Ansari, S., Rahmani, F., Taheri, H., and Nooripoor Sisakht, S. (2024). The Effect of Hydro-alcoholic Extracts of Salvia Officinalis Labiatae and Nasturtium Officinale on Different Clinical and Standard Candida Isolates of Candida in Comparison with Fluconazole Drug. Armaghane Danesh, 29(4), 512-523.
36- Kaur, J., and Nobile, C. J. (2023). Antifungal drug-resistance mechanisms in Candida biofilms. Current opinion in microbiology, 71, 102237. https://doi. org/10.1016/ j.mib. 2022.102237
37- Govrins, M., and Lass-Flörl, C. (2024). Candida parapsilosis complex in the clinical setting. Nature Reviews Microbiology, 22(1), 46-59.
